12:00 AM
Jul 13, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Novexatin: Phase I/IIa started

NovaBiotics began a double-blind, placebo-controlled, German Phase I/IIa trial to evaluate topical Novexatin administered once daily for 28 days in 48 patients....

Read the full 90 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >